Board of Directors (2021)

The Board of Directors is the legally and financially responsible body that sets the strategic direction of TOPRA and makes sure that all is running smoothly. Board elections are held annually for Officers and every two years for Directors. Any member, wherever they live or whatever their regulatory experience, can stand for election.

The members of the Board in 2021 are:


Office Term Name Professional position 
 President 1 year Anne Nallen Director, Global Regulatory Affairs CMC
Alexion Pharmaceuticals, Ireland
President-Elect 1 year Elizabeth Madichie Director of Regulatory Affairs and Pharmacovigilance
Porton Biopharma, UK
Past-President 1 year

Stephen Hayes  

Associate Director, Regulatory Development
Norgine, UK


Directors with special geographic responsibilities *

Office Term  Name  Professional position
Europe 2 years Eva Kopecna   Head of Global Regulatory, Pharmacovigilance and Medical Affairs
Acino International AG, Switzerland 
North America 2 years Aman Khera
Global Head of Regulatory Strategy
Worldwide Clinical Trials, Canada 

* In first year of their term in 2021

Directors without portfolio **

Office Term Name Professional position
Director 2 yrs Janine Jamieson Founder and consultant, JCombinations AB; and EU Editor at IPQ Publications, Sweden
Director 2 yrs Aine Kane Associate Research Fellow (Regulatory CMC)
Director  2 yrs Evgenia Mengou Director
EV Pharma Solutions, UK
 Director 2 yrs Fiona Reekie Founder and Principal, Pintells Pharma Consulting; and Senior Director, Head of Global Regulatory Policy and Intelligence, Global Regulatory Affairs, UCB, UK

** In second year of their term in 2021

Angela StokesBeing a member of the Board has given me insights into the running of a boardroom, I have been given an opportunity to shape the future of OUR professional organisation and I have met and worked with a great bunch of people.”

Angela Stokes
TOPRA President 2018